Ignacio Martin-Loeches1,2, Marcus J Schultz3, Jean-Louis Vincent4, Francisco Alvarez-Lerma5, Lieuwe D Bos3, Jordi Solé-Violán6, Antoni Torres7, Alejandro Rodriguez8,9. 1. Multidisciplinary Intensive Care Research Organization (MICRO), Wellcome Trust-HRB Clinical Research, Department of Clinical Medicine, Trinity Centre for Health Sciences, St James's University Hospital, Dublin, Ireland. drmartinloeches@gmail.com. 2. CIBERes, Madrid, Spain. drmartinloeches@gmail.com. 3. Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands. 4. Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium. 5. Service of Intensive Care Medicine, Parc de Salut Mar, Universitat Autonoma de Barcelona, Barcelona, Spain. 6. Intensive Care Unit, Hospital Universitario Dr. Negrín, CIBERES, Las Palmas de Gran Canaria, Spain. 7. Hospital Clinic Barcelona, Universidad Barcelona, CIBERES, Barcelona, Spain. 8. Centro de Investigación Biomédica En Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain. 9. Critical Care Department, Institut d'Investigació Sanitària Pere Virgili (IISPV), Joan XXIII University Hospital, Universitat Rovira i Virgili, Tarragona, Spain.
Abstract
BACKGROUND: Co-infection is frequently seen in critically ill patients with influenza, although the exact rate is unknown. We determined the rate of co-infection, the risk factors and the outcomes associated with co-infection in critically ill patients with influenza over a 7-year period in 148 Spanish intensive care units (ICUs). METHODS: This was a prospective, observational, multicentre study. Influenza was diagnosed using the polymerase chain reaction. Co-infection had to be confirmed using standard bacteriological tests. The primary endpoint of this analysis was the presence of community-acquired co-infection, with secondary endpoints including ICU, 28-day and hospital mortality. RESULTS: Of 2901 ICU patients diagnosed with influenza, 482 (16.6 %) had a co-infection. The proportion of cases of co-infection increased from 11.4 % (110/968) in 2009 to 23.4 % (80/342) in 2015 (P < 0.001). Compared with patients without co-infection, patients with co-infection were older [adjusted odds ratio (aOR) 1.1, 95 % confidence interval 1.1-1.2; P < 0.001] and were more frequently immunosuppressed due to existing HIV infection (aOR 2.6 [1.5-4.5]; P < 0.001) or preceding medication (aOR 1.4 [1.1-1.9]; P = 0.03). Co-infection was an independent risk factor for ICU mortality (aOR 1.4 [1.1-1.8]; P < 0.02), 28-day mortality (aOR 1.3 [1.1-1.7]; P = 0.04) and hospital mortality (aOR 1.9 [1.5-2.5]; P < 0.001). CONCLUSIONS: Co-infection in critically ill patients with influenza has increased in recent years. In this Spanish cohort, age and immunosuppression were risk factors for co-infection, and co-infection was an independent risk factor for ICU, 28-day and hospital mortality.
BACKGROUND: Co-infection is frequently seen in critically ill patients with influenza, although the exact rate is unknown. We determined the rate of co-infection, the risk factors and the outcomes associated with co-infection in critically ill patients with influenza over a 7-year period in 148 Spanish intensive care units (ICUs). METHODS: This was a prospective, observational, multicentre study. Influenza was diagnosed using the polymerase chain reaction. Co-infection had to be confirmed using standard bacteriological tests. The primary endpoint of this analysis was the presence of community-acquired co-infection, with secondary endpoints including ICU, 28-day and hospital mortality. RESULTS: Of 2901 ICU patients diagnosed with influenza, 482 (16.6 %) had a co-infection. The proportion of cases of co-infection increased from 11.4 % (110/968) in 2009 to 23.4 % (80/342) in 2015 (P < 0.001). Compared with patients without co-infection, patients with co-infection were older [adjusted odds ratio (aOR) 1.1, 95 % confidence interval 1.1-1.2; P < 0.001] and were more frequently immunosuppressed due to existing HIV infection (aOR 2.6 [1.5-4.5]; P < 0.001) or preceding medication (aOR 1.4 [1.1-1.9]; P = 0.03). Co-infection was an independent risk factor for ICU mortality (aOR 1.4 [1.1-1.8]; P < 0.02), 28-day mortality (aOR 1.3 [1.1-1.7]; P = 0.04) and hospital mortality (aOR 1.9 [1.5-2.5]; P < 0.001). CONCLUSIONS: Co-infection in critically ill patients with influenza has increased in recent years. In this Spanish cohort, age and immunosuppression were risk factors for co-infection, and co-infection was an independent risk factor for ICU, 28-day and hospital mortality.
Authors: Zong-Mei Sheng; Daniel S Chertow; Xavier Ambroggio; Sherman McCall; Ronald M Przygodzki; Robert E Cunningham; Olga A Maximova; John C Kash; David M Morens; Jeffery K Taubenberger Journal: Proc Natl Acad Sci U S A Date: 2011-09-19 Impact factor: 11.205
Authors: Ignacio Martín-Loeches; Ana Sanchez-Corral; Emili Diaz; Rosa María Granada; Rafael Zaragoza; Christian Villavicencio; Antonio Albaya; Enrique Cerdá; Rosa María Catalán; Pilar Luque; Amparo Paredes; Inés Navarrete; Jordi Rello; Alejandro Rodríguez Journal: Chest Date: 2010-10-07 Impact factor: 9.410
Authors: Ignacio Martin-Loeches; Elisabeth Papiol; Alejandro Rodríguez; Emili Diaz; Rafael Zaragoza; Rosa María Granada; Lorenzo Socias; Juan Bonastre; Montserrat Valverdú; Juan Carlos Pozo; Pilar Luque; Jose Antonio Juliá-Narvaéz; Lourdes Cordero; Antonio Albaya; Daniel Serón; Jordi Rello Journal: Crit Care Date: 2011-02-22 Impact factor: 9.097
Authors: Ignacio Martin-Loeches; Emili Díaz; Loreto Vidaur; Antoni Torres; Cesar Laborda; Rosa Granada; Juan Bonastre; Mar Martín; Josu Insausti; Angel Arenzana; Jose Eugenio Guerrero; Ines Navarrete; Jesus Bermejo-Martin; David Suarez; Alejandro Rodriguez Journal: Crit Care Date: 2011-11-28 Impact factor: 9.097
Authors: I Alfageme; J Aspa; S Bello; J Blanquer; R Blanquer; L Borderías; C Bravo; R de Celis; X de Gracia; J Dorca; J Gallardo; M Gallego; R Menéndez; L Molinos; C Paredes; O Rajas; J Rello; F Rodríguez de Castro; J Roig; F Sánchez-Gascón; A Torres; R Zalacaín Journal: Arch Bronconeumol Date: 2005-05 Impact factor: 4.872
Authors: Gennaro De Pascale; G Bello; A M Dell'Anna; L Montini; M Antonelli; Gerard Moreno; Alejandro Rodriguez; Ignacio Martin-Loeches Journal: Intensive Care Med Date: 2018-10-24 Impact factor: 17.440
Authors: Yingzhi Liu; Lowell Ling; Sunny H Wong; Maggie Ht Wang; J Ross Fitzgerald; Xuan Zou; Shisong Fang; Xiaodong Liu; Xiansong Wang; Wei Hu; Hung Chan; Yan Wang; Dan Huang; Qing Li; Wai T Wong; Gordon Choi; Huachun Zou; David Sc Hui; Jun Yu; Gary Tse; Tony Gin; William Kk Wu; Matthew Tv Chan; Lin Zhang Journal: EClinicalMedicine Date: 2021-06-10